Thomas M. Ashton
Creighton University(US)University of London(GB)Royal Historical Society(GB)UNESCO(FR)Museum of London(GB)King's College London(GB)University of Cambridge(GB)School of Advanced Study(GB)University of Oxford(GB)Historical Association(GB)London School of Hygiene & Tropical Medicine(GB)British Association for Slavonic and East European Studies(GB)Cambridge College(US)Science Oxford(GB)Universidad de Londres(MX)University College London(GB)Imperial College London(GB)Newcastle University(GB)London School of Economics and Political Science(GB)Birkbeck, University of London(GB)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, DNA Repair Mechanisms, Mitochondrial Function and Pathology, Cancer Immunotherapy and Biomarkers, Carcinogens and Genotoxicity Assessment
Most-Cited Works
- → Oxidative Phosphorylation as an Emerging Target in Cancer Therapy(2018)1,157 cited
- → The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia(2016)248 cited
- → T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics(2018)86 cited
- → Pathways for Holliday Junction Processing during Homologous Recombination in Saccharomyces cerevisiae(2011)62 cited
- → Yeast as a model system to study RecQ helicase function(2010)58 cited
- → Holliday junction-containing DNA structures persist in cells lacking Sgs1 or Top3 following exposure to DNA damage(2011)56 cited